Healthcare & Life Sciences
Guardian Bio
United Stateswww.guardian-bio.com
Guardian Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2020
Founded
2
Investors
About Guardian Bio
Based in the United States, Guardian Bio is a startup founded in 2020. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Guardian Bio develops a proprietary process to generate true cDC1 dendritic cells from patients’ stem cells to restore antigen presentation and enhance anti-cancer immunity in late stage solid tumor patients.
Explore Guardian Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.